DK525481A - Fremgangsmaade til fremstilling af pyrimidoner - Google Patents
Fremgangsmaade til fremstilling af pyrimidonerInfo
- Publication number
- DK525481A DK525481A DK525481A DK525481A DK525481A DK 525481 A DK525481 A DK 525481A DK 525481 A DK525481 A DK 525481A DK 525481 A DK525481 A DK 525481A DK 525481 A DK525481 A DK 525481A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimidones
- preparing
- procedure
- preparing pyrimidones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803046871 DE3046871A1 (de) | 1980-12-12 | 1980-12-12 | Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel |
| DE19813115447 DE3115447A1 (de) | 1981-04-16 | 1981-04-16 | Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK525481A true DK525481A (da) | 1982-06-13 |
Family
ID=25789685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK525481A DK525481A (da) | 1980-12-12 | 1981-11-26 | Fremgangsmaade til fremstilling af pyrimidoner |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4379788A (cs) |
| EP (1) | EP0054132B1 (cs) |
| AR (1) | AR227567A1 (cs) |
| AU (1) | AU543568B2 (cs) |
| CA (1) | CA1217767A (cs) |
| CS (1) | CS227024B2 (cs) |
| DD (1) | DD208151A5 (cs) |
| DE (1) | DE3166627D1 (cs) |
| DK (1) | DK525481A (cs) |
| ES (2) | ES8207156A1 (cs) |
| FI (1) | FI813971L (cs) |
| GB (1) | GB2090249B (cs) |
| GR (1) | GR76952B (cs) |
| HU (1) | HU187384B (cs) |
| IL (1) | IL64504A (cs) |
| MY (1) | MY8700562A (cs) |
| NO (1) | NO814239L (cs) |
| NZ (1) | NZ199254A (cs) |
| PH (1) | PH18930A (cs) |
| PL (1) | PL135330B1 (cs) |
| PT (1) | PT74116B (cs) |
| SU (1) | SU1056900A3 (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4460589A (en) * | 1980-10-03 | 1984-07-17 | The Upjohn Company | Process for treating hypertension |
| US4379778A (en) * | 1980-10-10 | 1983-04-12 | Air Products And Chemicals, Inc. | Hydrogen peroxide synthesis |
| DE3428476A1 (de) * | 1984-08-02 | 1986-02-13 | Basf Ag, 6700 Ludwigshafen | 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| DE3631294A1 (de) * | 1986-09-13 | 1988-03-24 | Thomae Gmbh Dr K | Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung |
| US5037980A (en) * | 1988-04-18 | 1991-08-06 | American Cyanamid Company | Phenyl imidazo[1,2-a]pyrimidines |
| GB8928346D0 (en) * | 1989-12-15 | 1990-02-21 | Smith Kline French Lab | Chemical compounds |
| GB9126260D0 (en) * | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
| GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
| DE19881732D2 (de) | 1997-11-12 | 2000-08-24 | Bayer Ag | 2-Phenyl-substituierte Imidazotriazinone als Phoshodiesterase Inhibitoren |
| RU2207337C2 (ru) * | 1998-11-18 | 2003-06-27 | Изаксон Елена Александровна | 6-(3-ацетилфенил)аминоурацил |
| US20040102324A1 (en) | 2002-02-28 | 2004-05-27 | Annis Gary David | Heterocyclic diamide invertebrate pest control agents |
| US6642244B2 (en) | 2001-03-16 | 2003-11-04 | Bristol-Myers Squibb Co. | Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase |
| EP1389103A4 (en) * | 2001-04-23 | 2005-09-14 | Univ Virginia | SYNTHESIS AND EVALUATION OF NEW PHTHALIMIDE COPIES AS ANTIANGIOGENIC AGENTS |
| EP1392314B1 (de) * | 2001-05-09 | 2006-12-20 | Bayer HealthCare AG | NEUE VERWENDUNG VON 2-[2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on |
| DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| EP1696927A4 (en) * | 2003-12-19 | 2007-10-31 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| SE0401345D0 (sv) * | 2004-05-25 | 2004-05-25 | Astrazeneca Ab | Therapeutic compounds: Pyridine as scaffold |
| SE0401342D0 (sv) * | 2004-05-25 | 2004-05-25 | Astrazeneca Ab | Therapeutic compounds |
| WO2005115993A1 (ja) * | 2004-05-31 | 2005-12-08 | Banyu Pharmaceutical Co., Ltd. | キナゾリン誘導体 |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| BRPI0616633A2 (pt) * | 2005-09-29 | 2011-06-28 | Bayer Healthcare Ag | inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos |
| CA2663436A1 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| EP2167057A1 (en) * | 2007-06-13 | 2010-03-31 | Bayer HealthCare AG | Pde inhibitors for the treatment of hearing impairment |
| CN101531638B (zh) * | 2008-03-13 | 2011-12-28 | 中国科学院广州生物医药与健康研究院 | 用作雌激素相关受体调节剂的化合物及其应用 |
| EP2273882A4 (en) * | 2008-05-13 | 2011-07-13 | Poniard Pharmaceuticals Inc | BIOACTIVE COMPOUNDS FOR THE TREATMENT OF CANCER AND NEURODEEGENERATIVE DISEASES |
| CN101628913B (zh) | 2008-07-18 | 2013-01-23 | 中国科学院广州生物医药与健康研究院 | 用作雌激素相关受体调节剂的化合物及其应用 |
| AU2013324681B2 (en) * | 2012-09-26 | 2017-08-10 | Merck Patent Gmbh | Quinazolinone derivatives as PARP inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3265697A (en) * | 1964-09-04 | 1966-08-09 | Shulton Inc | 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives |
| DE1939109A1 (de) * | 1968-08-31 | 1970-03-05 | Troponwerke Dinklage & Co | 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung |
| US3862191A (en) * | 1972-09-27 | 1975-01-21 | Pfizer | Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one |
-
1981
- 1981-10-21 EP EP81108623A patent/EP0054132B1/de not_active Expired
- 1981-10-21 DE DE8181108623T patent/DE3166627D1/de not_active Expired
- 1981-11-18 SU SU813354550A patent/SU1056900A3/ru active
- 1981-11-26 DK DK525481A patent/DK525481A/da not_active Application Discontinuation
- 1981-12-04 US US06/327,348 patent/US4379788A/en not_active Expired - Fee Related
- 1981-12-07 DD DD81235494A patent/DD208151A5/de unknown
- 1981-12-07 ES ES507761A patent/ES8207156A1/es not_active Expired
- 1981-12-10 IL IL64504A patent/IL64504A/xx unknown
- 1981-12-10 GR GR66768A patent/GR76952B/el unknown
- 1981-12-10 CS CS819180A patent/CS227024B2/cs unknown
- 1981-12-10 PL PL1981234175A patent/PL135330B1/pl unknown
- 1981-12-10 FI FI813971A patent/FI813971L/fi not_active Application Discontinuation
- 1981-12-11 CA CA000392067A patent/CA1217767A/en not_active Expired
- 1981-12-11 PT PT74116A patent/PT74116B/pt unknown
- 1981-12-11 AR AR287776A patent/AR227567A1/es active
- 1981-12-11 PH PH26759A patent/PH18930A/en unknown
- 1981-12-11 AU AU78473/81A patent/AU543568B2/en not_active Ceased
- 1981-12-11 GB GB8137458A patent/GB2090249B/en not_active Expired
- 1981-12-11 NZ NZ199254A patent/NZ199254A/en unknown
- 1981-12-11 HU HU813747A patent/HU187384B/hu unknown
- 1981-12-11 NO NO814239A patent/NO814239L/no unknown
-
1982
- 1982-04-30 ES ES82511835A patent/ES8304096A1/es not_active Expired
-
1987
- 1987-12-30 MY MY562/87A patent/MY8700562A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO814239L (no) | 1982-06-14 |
| MY8700562A (en) | 1987-12-31 |
| PL234175A1 (cs) | 1982-08-16 |
| ES511835A0 (es) | 1983-02-16 |
| CA1217767A (en) | 1987-02-10 |
| EP0054132B1 (de) | 1984-10-10 |
| GB2090249A (en) | 1982-07-07 |
| CS227024B2 (en) | 1984-04-16 |
| AU7847381A (en) | 1982-06-17 |
| ES8304096A1 (es) | 1983-02-16 |
| FI813971A7 (fi) | 1982-06-13 |
| HU187384B (en) | 1985-12-28 |
| NZ199254A (en) | 1985-02-28 |
| AR227567A1 (es) | 1982-11-15 |
| IL64504A0 (en) | 1982-03-31 |
| PL135330B1 (en) | 1985-10-31 |
| US4379788A (en) | 1983-04-12 |
| PH18930A (en) | 1985-11-11 |
| PT74116A (de) | 1982-01-01 |
| ES507761A0 (es) | 1982-09-01 |
| AU543568B2 (en) | 1985-04-26 |
| ES8207156A1 (es) | 1982-09-01 |
| DE3166627D1 (en) | 1984-11-15 |
| SU1056900A3 (ru) | 1983-11-23 |
| GB2090249B (en) | 1984-08-22 |
| PT74116B (de) | 1983-12-19 |
| FI813971L (fi) | 1982-06-13 |
| EP0054132A1 (de) | 1982-06-23 |
| DD208151A5 (de) | 1984-03-28 |
| GR76952B (cs) | 1984-09-04 |
| IL64504A (en) | 1985-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK525481A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
| DK350083D0 (da) | Fremgangsmade til fremstilling af phenylethanolaminer | |
| DK54879A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
| DK354281A (da) | Fremgangsmaade til geninkorporering af kakaoaroma | |
| DK299483D0 (da) | Fremgangsmade til fremstilling af n-phosphonomethylglycin | |
| DK55790A (da) | Fremgangsmaade til fremstilling af alfa-sulfonyloxyketonacetaler | |
| DK400381A (da) | Fremgansmaade til fremstilling af penicillanoyloxymethyl-penicillanoyloxymethyl-penicillanat-1,1,1!,1!-tetraoxid | |
| DK159681A (da) | Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer | |
| DK489381A (da) | Fremgangsmaade til fremstilling af aminopropoxyphenylderivater | |
| DK553582A (da) | Fremgangsmaade til fremstilling af naphthoxyalkylaminer | |
| DK283083A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
| DK501781A (da) | Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater | |
| DK115581A (da) | Fremgangsmaade til fremstilling af pyrimidylquinazoliner | |
| DK451883D0 (da) | Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler | |
| DK372081A (da) | Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater | |
| DK529181A (da) | Fremgangsmaade til fremstilling af substituerede benzamider | |
| DK142381A (da) | Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser | |
| DK231581A (da) | Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater | |
| DK226881A (da) | Fremgangsmaade til fremstilling af 3-picolin | |
| DK394783A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
| DK361983A (da) | Fremgangsmaade til fremstilling af meldroejealkaloider | |
| DK371981A (da) | Fremgangsmaade til fremstilling af aminoacetonitrilderivater | |
| DK449881A (da) | Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater | |
| DK399783D0 (da) | Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler | |
| DK411881A (da) | Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |